The Interaction between Syntaxin 1A and Cystic Fibrosis Transmembrane Conductance Regulator Clminus Channels Is Mechanistically Distinct from Syntaxin 1A-SNARE Interactions*

Radhika GaneshanDagger , Anke Di§, Deborah J. Nelson§, Michael W. Quick, and Kevin L. KirkDagger ||

From the Dagger  Department of Physiology and Biophysics, Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama 35294, the § Department of Neurobiology, Pharmacology, and Physiology, University of Chicago, Chicago, Illinois 60637, and the  Department of Biological Sciences, University of Southern California, HNB 228, Los Angeles, California 90089

Received for publication, November 19, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Syntaxin 1A binds to and inhibits epithelial cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels and synaptic Ca2+ channels in addition to participating in SNARE complex assembly and membrane fusion. We exploited the isoform-specific nature of the interaction between syntaxin 1A and CFTR to identify residues in the H3 domain of this SNARE (SNARE motif) that influence CFTR binding and regulation. Mutating isoform-specific residues that map to the surface of syntaxin 1A in the SNARE complex led to the identification of two sets of hydrophilic residues that are important for binding to and regulating CFTR channels or for binding to the syntaxin regulatory protein Munc-18a. None of these mutations affected syntaxin 1A binding to other SNAREs or the assembly and stability of SNARE complexes in vitro. Conversely, the syntaxin 1A-CFTR interaction was unaffected by mutating hydrophobic residues in the H3 domain that influence SNARE complex stability and Ca2+ channel regulation. Thus, CFTR channel regulation by syntaxin 1A involves hydrophilic interactions that are mechanistically distinct from the hydrophobic interactions that mediate SNARE complex formation and Ca2+ channel regulation by this t-SNARE.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The cystic fibrosis transmembrane conductance regulator (CFTR)1 is a cyclic AMP-activated anion channel that mediates salt and fluid transport across epithelial cells (1). The CFTR protein consists of a symmetric arrangement of two membrane-spanning regions, two nucleotide binding domains (nucleotide binding domains 1 and 2), and a central regulatory domain with multiple phosphorylation sites (2). The amino-terminal cytoplasmic tail binds to syntaxin 1A, a component of the membrane traffic machinery, and this interaction is blocked by Munc-18, a high affinity, syntaxin-binding protein (3). Syntaxin 1A inhibits CFTR-mediated chloride currents in a variety of cell types and expression systems. This effect of syntaxin 1A on CFTR channel activity may be due to the fact that the amino-terminal cytoplasmic tail of CFTR, to which syntaxin 1A binds, regulates channel gating apparently by interacting with the regulatory domain and/or nucleotide binding domain 1 (4).

Syntaxin 1A is a t-SNARE that is highly expressed in neurons and, to a lesser extent, in a variety of epithelial cells (5). Together with SNAP-25 (another t-SNARE) and VAMP-2/synaptobrevin (a v-SNARE), syntaxin 1A assembles into core SNARE complexes that regulate membrane fusion at the presynaptic membrane in neurons. The ternary SNARE complex consists of a parallel four-helix bundle containing one coiled-coil domain each from syntaxin and VAMP-2/synaptobrevin and two from SNAP-25 (6). The four associating alpha -helices contain hydrophobic residues that are grouped into "layers" that zipper together the four-helix bundle, resulting directly or indirectly in bilayer mixing. This paradigm applies to nonneuronal as well as to neuronal fusion events; in the former case, other SNARE isoforms are involved. The interactions among v-SNAREs and t-SNAREs are typically nonselective, at least in vitro (7), presumably because hydrophobic residues that are common to multiple isoforms mediate these interactions.

The helical region of syntaxin 1A that participates in SNARE complex assembly, termed the SNARE motif or the H3 domain (8), is proximal to the COOH-terminal membrane anchor region and lies downstream of another helical domain referred to as Habc. The SNARE motif, which forms an amphipathic helix, is composed of residues that are arranged in a heptad repeat manner designated a-g. The residues that map to heptad positions a and d are typically hydrophobic, well conserved across various syntaxin isoforms, and usually buried in the hydrophobic core of the SNARE complex. Conversely, residues at the b, c, and f heptad positions are more variable and are exposed on the surface of the ternary complex. The cytoplasmic domain of syntaxin 1A, encompassing the Habc and H3 domains, also interacts with Munc-18a with high affinity, and this interaction prevents syntaxin 1A from participating in SNARE complex assembly in vitro (9).

In addition to its role in the assembly of SNARE complexes, syntaxin 1A also has been reported to modulate multiple types of ion channels and transporters (3, 10-12). For example, syntaxin 1A inhibits the activities of several types of voltage-gated Ca2+ channels in a variety of expression systems and cell types. It has been proposed that the simultaneous association of syntaxin 1A with synaptic vesicle proteins and voltage-gated Ca2+ channels may help couple SNARE complex formation/dissociation to the influx of Ca2+ at neurotransmitter release sites (13). With respect to CFTR-syntaxin interactions, syntaxin 1A, but not any other isoform that has been tested (i.e. syntaxins 2-5), binds to the CFTR amino-terminal tail (N-tail) and inhibits channel activity (5).2 In addition, CFTR binds to the H3 domain of syntaxin 1A, and soluble syntaxin 1A peptides that lack the transmembrane region but include the H3 region can rescue CFTR-mediated currents from inhibition by membrane-anchored syntaxin 1A (3, 5). As argued for the syntaxin 1A-Ca2+ channel interaction, the interaction between this t-SNARE and CFTR channels may help synchronize the activity of this channel with protein traffic in epithelial cells. Thus, the ability of syntaxin 1A to influence the function of ion channels and to couple their activity to membrane traffic may be a general phenomenon. However, it is not clear if the structural basis of the interactions between syntaxin 1A and different ion channels is similar. In this regard, Bezprozvanny et al. (14) have reported that the regulation of voltage-gated Ca2+ channels by syntaxin 1A is disrupted by point mutations in specific hydrophobic residues in the H3 domain that are also implicated in SNARE complex stability.

In the present study, we exploited the isoform specificity of the syntaxin 1A interaction with CFTR to identify unique residues in the H3 domain of syntaxin 1A that participate in CFTR binding and channel regulation. These residues are hydrophilic and are located in the outer shell of the SNARE complex structure (i.e. distinct from those in the hydrophobic layers that stabilize the SNARE complex). Mutating these residues diminished both the physical and functional interactions of syntaxin 1A with CFTR but had no effect on the biochemical association of syntaxin 1A with other SNARE proteins or with Munc-18. Conversely, the CFTR-syntaxin 1A interaction was not affected by mutations in specific hydrophobic residues of the H3 domain that disrupt Ca2+ channel regulation and compromise SNARE stability. Our results indicate that syntaxin 1A regulates CFTR channels by a protein-protein interaction that is mechanistically distinct from how syntaxin 1A participates in SNARE complex assembly or regulates voltage-gated calcium channels.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Antibodies-- A mouse monoclonal antibody to syntaxin 1A (Cl 78.3) was obtained from Synaptic Systems (Germany). An affinity-purified polyclonal antibody raised against human SNAP-23 and a mouse monoclonal antibody raised against the COOH-terminal tail of human CFTR have been described earlier (15). A mouse monoclonal antibody raised against Munc-18a was purchased from Transduction Laboratories.

cDNA Constructs and Purification of GST Fusion Proteins-- The cDNA encoding human syntaxin 1A was obtained from a T84 cDNA library (3). Single and double alanine or leucine substitutions in the H3 domain of syntaxin 1A were generated by PCR mutagenesis. An appropriate mutagenic oligonucleotide was incorporated in the PCR reaction using cDNA encoding human syntaxin 1A as template. The upstream primer contained an EcoRI site, and the downstream primer included a XhoI site. After digestion with EcoRI and XhoI, the PCR product was ligated back into the appropriate sites in the pCDNA3 eukaryotic expression vector (Invitrogen). The cytosolic region (residues 1-266) of syntaxin 1A was amplified by PCR and subcloned into pGEX bacterial GST fusion protein expression vector (Amersham Biosciences). All point mutations were confirmed by DNA sequencing of the entire coding region of the syntaxin 1A cytosolic domain. Full-length rat syntaxin 1A mutated at two hydrophobic residues (A240V/V244A) was a gift from I. Bezprozvanny and R. Tsien (14). The cytosolic region (residues 1-266) of this syntaxin 1A mutant and the full-length coding region were amplified by PCR and subcloned into pGEX-5X-1 and pCDNA3, respectively. All GST-syntaxin 1A fusion proteins (GST-syn1ADelta C; Delta C refers to deletion of the COOH-terminal membrane domain) and GST alone were expressed and purified from bacterial cells and dialyzed against phosphate-buffered saline as described (16). GST fusion constructs for mouse SNAP25 (residues 1-206) and rat VAMP2/synaptobrevin (residues 1-94) were gifts of Drs. J. Pevsner and M. Bennett, respectively, and have been described previously (17, 18). In experiments where GST-free proteins were used, fusion proteins were cleaved with thrombin as described (19). Protein concentrations were estimated by standard micro-BCA protein assay (Pierce) or by Coomassie Blue staining of protein bands after SDS-PAGE using bovine serum albumin as a standard.

Cell Culture and Lysate Preparation-- BHK cells that were stably transfected with full-length wild-type human CFTR were a gift from J. W. Hanrahan and were cultured as described (20). HT29-Cl19A human colonic epithelial cells expressing native CFTR, SNAP23, and Munc18 were propagated as described previously (3). Mouse L-fibroblasts stably transfected with full-length human CFTR and full-length human syntaxin 1A have been described previously (15). Cells grown in 10-cm dishes were lysed in situ on ice with chilled lysis buffer (phosphate-buffered saline containing 1% (v/v) Triton X-100, 5% (v/v) glycerol, 1 mM dithiothreitol, and a protease inhibitor mixture of aprotinin, pepstatin A, and leupeptin at 2 µg/ml each and phenylmethylsulfonyl fluoride at 1 mM). Lysates were centrifuged at 10,000 × g (4 °C) to remove cell debris before being used for binding assays.

Binding Assays-- The indicated amounts of the GST-syn1ADelta C proteins were added to clarified cell lysates (1-ml final reaction volume) and incubated overnight (12-16 h) at 4 °C on a rotator. For titration binding experiments, the lysates were diluted in lysis buffer before adding fusion protein. The complexes were captured by mixing with excess glutathione-Sepharose for 2 h, and the beads were washed in several volumes of lysis buffer minus the protease inhibitors. The bound proteins were eluted with Laemmli buffer and separated by SDS-PAGE on 4-20% gradient gels (Bio-Rad) followed by immunoblotting on polyvinylidene difluoride membranes (PerkinElmer Life Sciences) using conditions described (5). CFTR immunoprecipitations were carried out to monitor CFTR protein levels in the lysates as described previously (15). The immunoreactive protein bands were visualized by enhanced chemiluminescence (Pierce). Signals were quantified by densitometric scanning followed by analysis with Scion Image (release beta 4.0.2) (Scion Corp.).

Analysis of SDS-resistant SNARE Complexes-- Binary or ternary combinations of GST-free wild-type or mutant syntaxin 1A (residues 1-266), SNAP25, and VAMP2/synaptobrevin (residues 1-94) (2 µM each) were mixed overnight (16 h) at 4 °C as described (19). After the addition of Laemmli buffer, samples were divided into two aliquots. One aliquot was incubated at 37 °C for 3 min and the other at 100 °C for 3 min. To generate the thermal melting profiles of the ternary complexes, the samples were divided into 14 aliquots after adding Laemmli buffer containing 2% SDS and incubated at temperatures between 25 and 100 °C (in increments of 6 °C) for 3 min in a programmable thermal cycler (MJ Research). The samples were resolved by SDS-PAGE on 4-20% gradient gels (Bio-Rad) and immunoblotted for syntaxin 1A. To quantitate the dissociation of the complexes, the signal intensities of the 100- and 200-kDa complexes were measured by densitometric scanning for each point on the temperature axis and normalized to the signal intensity of the complexes at 25 °C (100%). For SNARE titration experiments, various concentrations (0.05-1 µM) of recombinant SNAP25 were added to a binary mixture containing 1 µM each of recombinant syntaxin 1A (wild-type or mutant) and VAMP2/synaptobrevin and mixed overnight (16 h) at 4 °C as above. After the addition of Laemmli buffer, samples were incubated at 37 °C for 3 min and immunoblotted for syntaxin 1A.

Electrophysiology-- The methods and solutions used for the Xenopus oocyte expression studies are described in detail elsewhere (16). The methods for the whole-cell patch clamp experiments performed on L-fibroblasts stably transfected with CFTR and syntaxin 1A are similar to those described earlier (15). The pipette solution contained 140 mM N-methyl-D-glucamine, 40 mM HCl, 100 mM L-glutamic acid, 0.2 mM CaCl2, 2 mM MgCl2, 1 mM EGTA, 10 mM HEPES, and 5 mM ATP-Mg, pH 7.2. The bath solution contained 140 mM NMDG, 140 mM HCl, 2 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES, pH 7.4. CFTR-mediated Cl- current was induced within 10-15 min of breaking into the cell by perfusion with a mixture containing 10 µM forskolin, 1 mM isobutylmethylxanthine, and 400 µM cpt-cAMP. cAMP-activated currents were recorded at +110 mV from a holding potential of -40 mV. All experiments were performed at 22-24 °C.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutating Syntaxin 1A at Isoform-specific Residues Inhibits CFTR Binding or Munc-18 Binding-- Our previous findings indicated that CFTR channels physically and functionally interact with human or mouse syntaxin 1A but not with syntaxins 2-5 (5). Therefore, we mutated four residues in the H3 domain of syntaxin 1A that are unique to this isoform and that are well conserved across species (namely Ser225, Tyr235, Glu238, and Val248 (see Fig. 1). These residues were replaced with alanine singly or in combination. In addition, we replaced Glu238 with leucine, since human syntaxins 4 and 5 have leucine at the corresponding position. The abilities of these syntaxin 1A mutants to bind to CFTR as well as to SNAP-23 (a t-SNARE) and to Munc-18 were tested using the indicated GST-syn1ADelta C proteins to pull down native proteins from HT29-Cl19A epithelial cell lysates (Fig. 2A). Introducing the alanine substitutions at residues Ser225 and Glu238 (singly or in combination) as well as the leucine substitution at Glu238 of syntaxin 1A resulted in a substantial loss of binding to CFTR as compared with the wild-type protein (upper panel). The E238A and E238L mutations had a more pronounced effect on CFTR binding than the S225A mutation (see also Fig. 3A). Conversely, mutating Tyr235 or Val248 did not appreciably reduce syntaxin 1A binding to CFTR. Of all the syntaxin 1A mutants that were tested, only the tyrosine mutant (Y235A) showed a marked decrease in its binding to Munc-18 (middle panel). Notably, none of the syntaxin 1A mutants that showed reduced binding to CFTR or to Munc-18 were affected for binding to SNAP-23 (bottom panel). GST alone was used as a negative control in all binding experiments and did not bind to any of the target proteins.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 1.   Domain organization (bottom) and sequence alignment of the SNARE motif of human syntaxin isoforms (top) and of the corresponding regions in syntaxin 1A of human (hum), mouse (mou), and Drosophila (drome) (middle). Heptad positions a-g are indicated below the sequences. Hydrophobic residues at the a and d heptad positions are boxed. Residues unique to the syntaxin 1A isoform are in boldface type, and the corresponding residues in all isoforms are shaded.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Screening of syntaxin 1A mutants for CFTR, Munc-18, and SNAP-23 binding. A, GST alone or GST fusion proteins of the cytosolic domain of the wild-type (WT) or indicated syntaxin 1A mutants (0.5 µM each) were used to pull down native CFTR, Munc-18, and SNAP-23 from HT29-Cl19A cell lysates. Band C represents mature, fully glycosylated CFTR. Since CFTR is less abundant than SNAP-23 and Munc-18 in these cells, a more concentrated lysate (5×) was used for the CFTR pull-down. This experiment was repeated 10 times with similar results. B, recombinant CFTR was pulled down from BHK cell lysates with the indicated amounts of wild-type or E238A GST-syn1ADelta C proteins. The graph shows the CFTR binding signals for each fusion protein as a function of protein concentration. Data points represent means ± S.E. calculated from three separate experiments. All binding signals were normalized to the CFTR binding signal at 2 µM wild-type GST-syn1ADelta C. C, recombinant CFTR and native SNAP-23 were pulled down from BHK cell lysates (at the indicated dilutions) with the indicated GST-syn1ADelta C proteins (0.25 µM). Control pull-downs with GST and GST-syn3Delta C (0.25 µM each) were performed using undiluted lysates. D, native Munc-18 and SNAP-23 were pulled down from HT29-Cl19A lysates with the indicated GST-syn1ADelta C proteins (0.5 µM).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   CFTR binding is inhibited by mutating hydrophilic residues but not hydrophobic residues of syntaxin 1A. A, recombinant CFTR was pulled down from BHK cell lysates with the indicated GST-syn1ADelta C proteins (0.25 µM). CFTR was immunoprecipitated from undiluted lysate using a CFTR antibody (2 µg) (IP). Note that mutating residue Ser225 alone produced an intermediate effect on CFTR binding as compared with mutating E238A alone or mutating both residues. B, recombinant CFTR and native SNAP-23 were pulled down from BHK cell lysates with indicated GST-syn1ADelta C proteins or GST alone (0.5 µM each). Mutating the hydrophobic residues at positions 240 and 244 had no effect on CFTR binding.

Since the E238A mutation resulted in the greatest loss of binding to CFTR, we performed titration experiments over a range of protein concentrations to provide a semiquantitative index of the binding strength of this mutant versus wild-type syntaxin 1A. To detect CFTR binding signals over a broad range of CFTR protein amounts and syntaxin 1A concentrations, we used lysates made from BHK cells that express high levels of recombinant CFTR. In the first assay, recombinant CFTR was pulled down with varying amounts of GST-syn1ADelta C (wild-type or E238A) added to a fixed volume of BHK cell lysate. The amount of CFTR that bound to the E238A mutant was considerably lower at all concentrations tested (Fig. 2B). Binding appeared to saturate between 1 and 2 µM for both the wild-type and mutant syntaxin 1A fusion proteins (see "Discussion" for explanation). In a complementary assay, various dilutions of BHK cell lysates containing recombinant CFTR and native SNAP-23 were incubated with a fixed concentration of wild-type or mutant GST-syn1ADelta C. As seen from the upper panel of Fig. 2C, the CFTR binding signal was substantially lower for the E238A mutant as compared with wild-type protein at all lysate dilutions. However, the SNAP-23 binding signals were comparable for both syntaxin 1A fusion constructs at all lysate dilutions (lower panel). GST and GST-syn3Delta C were used as controls, and, as expected, GST-syn3Delta C could bind SNAP-23 but not CFTR, whereas GST alone could bind neither. In summary, the data obtained from multiple binding assays performed using either native or recombinant CFTR indicate that the E238A syntaxin 1A mutant is specifically inhibited for CFTR binding.

Similar titration experiments were performed to compare the binding of Y235A, E238A, and wild-type syntaxin 1A to Munc-18 and SNAP-23 using fixed amounts of GST-syn1ADelta C fusion proteins and varying dilutions of HT29-Cl19A epithelial cell lysates. As shown in the upper panel of Fig. 2D, the Y235A mutant showed considerably reduced Munc-18 binding as compared with wild-type or E238A syntaxin 1A even at the highest concentration of lysate. All three syntaxin 1A fusion proteins showed comparable binding to SNAP-23. In summary, we have generated point mutations in the H3 domain of syntaxin 1A that differentially inhibit binding to CFTR (S225A and E238A,L) and to Munc-18 (Y235A). Both types of mutations map to residues that are not implicated directly in SNARE complex formation (i.e. heptad positions b, c, and f), and, as expected, neither inhibited SNAP-23 binding.

CFTR Binding Is Not Inhibited by Mutating Hydrophobic Residues Implicated in SNARE Complex Formation and Ca2+ Channel Regulation (A240V/V244A)-- Since the preceding results indicate that two hydrophilic residues (Ser225 and Glu238) of syntaxin 1A are important for its interaction with CFTR, we next examined the effect of mutating residues buried in the hydrophobic layers of the SNARE complex on CFTR binding. For this purpose, we selected a syntaxin 1A double mutant, A240V/V244A, in which the mutated residues map to the a and d heptad positions predicted to be in the hydrophobic core of the SNARE complex. Another important feature of this double mutant is that it was reported to be ineffective for regulating N-type Ca2+ channels in functional assays (14). We compared the CFTR binding of this double mutant with that exhibited by another double mutant in which the two hydrophilic residues that were implicated in CFTR binding based on the preceding data (Figs. 2 and 3A) were converted to alanine (S225A/E238A). As seen in Fig. 3B (upper panel), the A240V/V244A double mutant is not inhibited for binding CFTR unlike the S225A/E238A double mutant. Although residues Ala240 and Val244 are implicated in mediating SNARE-SNARE interactions, due to their location in the hydrophobic layers, the double mutation at these positions did not inhibit binding of syntaxin 1A to SNAP-23 in these pull-down experiments (see Fig. 3, lower panel). However, in studies described below, the A240V/V244A double mutation was found to destabilize core SNARE complexes assembled in vitro.

The E238A Mutation Does Not Inhibit the Formation of SDS-resistant SNARE Complexes in Vitro-- A hallmark feature of syntaxin 1A is its ability to assemble into SDS-resistant complexes with SNAP-25 and VAMP-2 in vitro that mimic the properties of native fusion complexes isolated from brain vesicles (21). Accordingly we tested the abilities of the syntaxin 1A mutants to form SDS-resistant complexes with recombinant SNAP-25 and VAMP-2 proteins. As shown in Fig. 4A, at least three prominent high molecular weight complexes, presumably representing monomers (50-70 kDa) and multimers (>100 kDa) of the core SNARE complexes, could be detected when either wild-type or E238A syntaxin 1A was mixed with SNAP-25 and VAMP-2. These complexes were resistant to SDS at 37 °C but could be melted by heating to 100 °C. As expected, SDS-resistant complex formation required all three proteins. To rule out a more subtle effect of the E238A mutation on SNARE complex assembly, we also performed a titration experiment in which we monitored SDS-resistant complex formation induced by mixing increasing amounts of SNAP-25 with fixed amounts of VAMP-2 and syntaxin 1A (wild-type or E238A). As seen from Fig. 4B, titrating in increasing amounts of SNAP-25 resulted in an increased appearance of SDS-resistant complexes to the same extent for either wild-type or E238A syntaxin 1A. Thus, a mutation that profoundly affects the binding of syntaxin 1A to CFTR produced no discernible effect on its ability to form SDS-resistant SNARE complexes with VAMP-2 and SNAP-25.


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 4.   The E238A mutation does not inhibit the formation of SDS-resistant SNARE complexes. A, binary or ternary complexes of GST-free, wild-type (WT), or E238A syntaxin 1A, SNAP-25, and VAMP-2 were incubated with Laemmli buffer (2% SDS) at the indicated temperatures and immunoblotted with syntaxin 1A antibody. SNAP-25 was used in this assay, because formation of SDS-resistant SNARE complexes was not detected when SNAP-23 replaced SNAP-25 (28) (results not shown). Bands represent monomers (50-70 kDa) and multimers (>100 kDa) of core SNARE complexes. The lowest band at ~25 kDa represents cross-reactivity of the syntaxin 1A antibody with SNAP-25. B, soluble SNAP-25 was titrated into a binary mixture (1 µM each) of soluble VAMP-2 and wild-type or E238A syntaxin 1A, and the resulting complexes were analyzed by immunoblotting for syntaxin 1A.

Mutating Hydrophobic Residues (A240V/V244A) Destabilizes SNARE Complexes, but Mutating Hydrophilic Residues That Participate in CFTR Binding (Ser225 and Glu238) Does Not-- The steady-state formation of SNARE complexes at 37 °C may not be a sensitive indicator of subtle effects of syntaxin 1A mutations on the stability of these complexes. Thus, in order to examine whether point mutations in syntaxin 1A altered the stability of the ternary complexes, we compared the thermal melting profiles of SNARE complexes assembled using wild-type and mutant syntaxin 1A proteins. In complexes assembled with wild-type syntaxin 1A (Fig. 5A), the major complexes of sizes 50-70, 100, and 200 kDa began dissociating around 60 °C, and the larger two complexes could not be detected beyond 67 °C, similar to previous findings (19). The melting profile for E238A was similar to that observed for the wild-type protein (Fig. 5B), which was verified by quantifying the dissociation of SNARE complexes as a function of increasing temperature (Fig. 5C).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 5.   Thermostabilities of SNARE complexes assembled with wild-type and mutant syntaxin 1A. SNARE complexes assembled using wild-type (A) or E238A syntaxin 1A (B) were incubated with Laemmli buffer (2% SDS) at the indicated temperatures and immunoblotted for syntaxin 1A. C and D, the signal intensities of the 100- and 200-kDa bands were plotted as a function of the incubation temperature for SNARE complexes that were assembled using the wild-type (WT) or E238A, S225A/E238A, or A240V/V244A mutant, respectively. The intensities of the two bands were summed for each experiment and then averaged over three separate experiments. The data points represent means ± S.E. calculated from three experiments. An asterisk indicates p < 0.05 compared with wild-type (unpaired t test).

This analysis was next extended to the S225A/E238A and A240V/V244A double mutants that were also able to assemble SDS-resistant SNARE complexes with SNAP-25 and VAMP-2 in vitro similar to wild-type and E238A syntaxin 1A (results not shown). Upon comparing the thermostabilities of the SNARE complexes (Fig. 5D), we observed a leftward shift in the melting curve for the A240V/V244A mutant (i.e. the core complexes began dissociating at a lower temperature when they were assembled with this mutant (49-55 °C) as compared with wild-type syntaxin 1A (61-67 °C)). On the other hand, complexes assembled with the S225A/E238A syntaxin 1A mutant exhibited very similar melting profiles as compared with wild-type syntaxin 1A. Thus, mutations that inhibit CFTR binding (E238A and S225A) do not detectably affect SNARE complex formation or stability in vitro. On the other hand, mutations that do destabilize SNARE complexes and inhibit Ca2+ channel regulation (A240V/V244A) do not appreciably affect CFTR binding (Fig. 3B).

Syntaxin 1A Mutants That Are Inhibited for Binding to CFTR Are Also Inhibited for Regulating CFTR-mediated Cl- Currents-- We next tested the abilities of these syntaxin 1A mutants to regulate CFTR-mediated chloride currents in order to determine (i) whether syntaxin 1A mutations that disrupt CFTR binding also inhibit CFTR channel regulation by this t-SNARE and (ii) whether syntaxin 1A mutations that destabilize SNARE complexes and inhibit regulation of voltage-gated Ca2+ channels (A240V/V244A) are disrupted for CFTR regulation. CFTR-mediated currents were measured in Xenopus oocytes co-expressing CFTR and full-length syntaxin 1A proteins by two-electrode voltage clamp analysis. As documented in Fig. 6A, CFTR-mediated currents in oocytes were inhibited in a dose-dependent manner when these oocytes were co-injected with increasing amounts of wild-type syntaxin 1A cRNA, as previously observed (3). Similar degrees of inhibition were observed when CFTR was co-expressed with the V248A and Y235A syntaxin 1A mutants that displayed wild-type levels of binding to CFTR (Fig. 2A). The A240V/V244A double mutant also inhibited CFTR-mediated currents like wild-type syntaxin 1A. On the other hand, the S225A mutation, which moderately compromised CFTR binding, and the E238A and S225A/E238A mutations, which severely inhibited CFTR binding (Fig. 3A), were moderately and severely inhibited for regulating CFTR currents. The attenuation of CFTR-mediated currents by wild-type or mutant syntaxin 1A could be reversed in all cases by first microinjecting into the oocytes botulinum neurotoxin C1 (BoNT/C1), a protease that cleaves syntaxin 1A (Fig. 6B). In order to verify that the relative ineffectiveness of certain syntaxin 1A mutants to inhibit CFTR currents was not due to poor protein expression, we immunoblotted oocyte membranes to confirm the expression of the various syntaxin 1A constructs (Fig. 6C). In combination with our binding data, the results of Fig. 6 indicate that (i) there is a strong correlation between CFTR binding strength and CFTR channel regulation for the various syntaxin 1A mutants that were tested and (ii) a syntaxin 1A mutation (A240V/V244A) that destabilizes SNARE complexes and that disrupts Ca2+ channel regulation in oocytes has no discernible effect on CFTR regulation in this expression system.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 6.   Mutations in syntaxin 1A that disrupt CFTR binding also disrupt regulation of CFTR-mediated currents in oocytes. A, peak cAMP-activated CFTR-mediated currents were recorded in oocytes injected with cRNAs for wild-type CFTR (1 ng) and the indicated amounts of wild-type or mutant full-length syntaxin 1A. For each data point, n = 8-19 oocytes. B, effect of BoNT/C1 (1 ng/oocyte) on CFTR-mediated currents in oocytes co-expressing wild-type or mutant syntaxin 1A (5 ng). cAMP-activated currents were recorded before and after BoNT/C1 injection in the same oocytes (n = 5-7 oocytes per data point). All values in A and B are normalized to the peak currents recorded in oocytes expressing CFTR alone. Data points represent means ± S.E. Statistical comparisons between two groups were performed using Student's t test. The asterisks indicate p < 0.05 relative to untreated samples. C, immunoblot analysis of oocyte membranes (10-12 oocytes/lane) to confirm the expression of recombinant wild-type or mutant syntaxin 1A. Control represents uninjected oocytes. Total membrane fraction was purified from oocytes and analyzed by immunoblotting (29).

In a complementary set of functional experiments, wild-type and mutant GST-syn1ADelta C proteins were screened for their abilities to stimulate CFTR-mediated Cl- currents in L-fibroblasts that were stably transfected with recombinant CFTR and full-length wild-type syntaxin 1A. Previously, we had shown that a GST fusion protein containing the soluble cytosolic domain of syntaxin 1A (GST-syn1ADelta C), when introduced into these cells via whole cell patch pipettes, could stimulate CFTR-mediated currents presumably by competing with the membrane-anchored syntaxin 1A for CFTR binding (15). This was also true for GST-syn1ADelta C containing the Y235A or A240/V244A mutations, both of which bind CFTR (Fig. 7). Conversely, the E238A mutant and to a lesser extent the S225A mutant (both of which showed reduced binding to CFTR) were compromised in their abilities to stimulate currents in this functional assay. Unexpectedly, the V248A mutant fusion protein, which does bind to CFTR, was also inactive when tested in this assay, despite the fact that the full-length V248A syntaxin 1A did inhibit CFTR-mediated currents in the oocyte expression system (Fig. 6). At present, we have no explanation for this disparity other than the possibility that the peptide rescue experiments may not provide a direct measure of the strength of the CFTR-syntaxin 1A interaction. Given that this assay may require that the GST-syn1ADelta C peptide disrupt CFTR interactions with multiple SNARE proteins (see "Discussion"), the binding assays and the oocyte expression experiments may provide more direct measures of the strength of the interaction between CFTR and syntaxin 1A.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   Mutant syntaxin 1A fusion proteins that are inhibited for binding to CFTR are also inhibited for stimulating CFTR-mediated Cl- currents in L-fibroblasts. Whole cell current measurements were performed as described under "Experimental Procedures." cAMP-induced increase in current density recorded at 110 mV is shown for cells in the absence (control) or presence of the indicated GST-syn1ADelta C peptides (0.35 µM) in the pipette solution. The number of cells per data point is shown in parentheses. Data are mean ± S.E. The asterisks indicate p < 0.05 relative to control determined by unpaired t test.

Munc-18 Is Unable to Rescue CFTR-mediated Currents from Inhibition by Y235A Syntaxin 1A-- Munc-18 blocks the inhibitory effect of syntaxin 1A on CFTR-mediated currents, due presumably to its ability to block the binding of syntaxin 1A to CFTR (4). In the present study, we identified a novel syntaxin 1A mutation (Y235A) that was inhibited for Munc-18 binding (Fig. 2, A and D). Furthermore, this mutant was able to interact with CFTR as detected in our in vitro binding experiments (Fig. 2A) and electrophysiological assays (Figs. 6A and 7). Accordingly, we examined the functional effect of this mutation in the context of the reciprocal regulation of CFTR by syntaxin 1A and Munc-18 by recording currents in Xenopus oocytes co-expressing the three proteins (Fig. 8A). Co-expression of Munc-18 could rescue CFTR currents from inhibition by wild-type syntaxin 1A in oocytes but not from inhibition by Y235A syntaxin 1A. The studies were next extended to L-fibroblasts expressing recombinant CFTR and syntaxin 1A, where CFTR-mediated currents were stimulated by GST-Munc-18a included in whole-cell patch pipettes. As reported previously (3), premixing of GST-Munc-18a with the soluble GST-syn1ADelta C peptide neutralized each other's stimulatory effect on CFTR currents, most likely by blocking the binding of this soluble syntaxin 1A peptide to CFTR. However, such a neutralizing effect was not observed when GST-Munc-18a was premixed with the mutant Y235A peptide. Thus, the regulatory effect of syntaxin 1A on CFTR was physically and functionally uncoupled from its interaction with Munc-18a by mutating residue Tyr235.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 8.   Munc-18 is unable to rescue CFTR-mediated currents from inhibition by Y235A syntaxin 1A. A, co-expression of Munc-18a blocks the inhibition of CFTR-mediated currents by full-length wild-type (WT) syntaxin 1A but not by Y235A syntaxin 1A in oocytes (n = 4-8 oocytes). Comparisons across multiple groups were performed using one-way analysis of variance followed by Tukey's honestly significant difference post hoc tests. The asterisks indicate p < 0.05 in comparison with CFTR alone (*) or in comparison with CFTR + wild-type syntaxin 1A (**). B, comparison of cAMP-activated current densities in L-cells in the absence or presence of 0.35 µM GST-syn1ADelta C (wild-type or Y235A) with or without 0.35 µM GST-Munc-18a in the patch pipette. The numbers in parentheses indicate the number of cells per data point.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Syntaxin 1A-CFTR Interaction Involves Hydrophilic Residues That Are Not Involved in SNARE-SNARE Interactions-- The goals of this project were to characterize the molecular basis of the interactions between syntaxin 1A and CFTR and to compare the nature of these interactions with that of SNARE-SNARE interactions. We identified two hydrophilic amino acids (Glu238 and Ser225) that are specific to the syntaxin 1A isoform and that are necessary for binding to CFTR and regulating its channel activity. Mutating these residues (E238A and S225A) disrupted the biochemical association of syntaxin 1A with CFTR and the ability of syntaxin 1A to modulate CFTR-mediated currents in the oocyte expression system. The mutations did not, however, inhibit syntaxin 1A binding to SNAP-23 or Munc-18; nor did they affect the ability of syntaxin 1A to assemble into SNARE complexes with SNAP-25 and VAMP-2 or the stability of these complexes. This is consistent with the positions of residues Glu238 and Ser225 on the outer surface (heptad positions b and c) of the ternary SNARE complex structure. Conversely, mutations in neighboring hydrophobic amino acids (A240V/V244A) that are located in the inner layers (heptad positions a and d), where they stabilize the core SNARE complex, did not detectably affect either the binding of syntaxin 1A to CFTR or its ability to regulate this channel. Thus, the nature of the syntaxin 1A-CFTR interaction appears to be mechanistically distinct from syntaxin 1A-SNARE interactions. The former involves hydrophilic surface residues that are specific to this isoform (Glu238 and Ser225), whereas the latter is mediated by hydrophobic residues present in other syntaxin isoforms and other SNAREs as well. This probably explains why CFTR regulation is specific to the syntaxin 1A isoform, whereas SNARE-SNARE interactions are promiscuous at least in vitro.

The E238A and S225A Mutations Do Not Produce Equivalent Effects on CFTR Binding-- The results of the titration binding assays indicated that mutating residue Ser225 alone produced an intermediate effect on CFTR binding as compared with mutating residue Glu238 alone or mutating both residues (S225A/E238A). Conceivably, the negative charge on the Glu238 residue may render it more important for mediating the CFTR-syntaxin 1A interaction. In this regard, the binding interaction between CFTR and syntaxin 1A is salt-sensitive,3 which implies that electrostatic interactions contribute to the binding between these two proteins. In our titration experiments, the CFTR binding signal for the E238A mutant was considerably lower as compared with the wild-type protein even at saturating concentrations. An explanation for this observation could be that CFTR binding at higher concentrations of syntaxin 1A is limited because of oligomerization of this t-SNARE. It has been shown that syntaxin 1A oligomerizes at protein concentrations >2 µM and that the homo-oligomers are not random aggregates but form parallel helices similar to SNARE complexes (22). Preliminary gel filtration analysis revealed that there was an increase in the oligomeric forms of both the wild-type and E238A syntaxin 1A fusion proteins as the protein concentration was increased from 0.5 to 2 µM. The E238A mutation per se had no apparent effect on oligomerization as analyzed in this manner (data not shown). Thus, although one might expect that the E238A mutant should be able to achieve wild-type levels of CFTR binding at higher protein concentrations (>2 µM), the decrease in the concentration of the form competent to bind CFTR might prevent this. It is also possible that the E238A mutation has an indirect effect on CFTR binding by altering multimerization (although see above) or by producing a conformational change in syntaxin 1A, which, in effect, would shield other residues in the H3 domain that mediate CFTR binding. On the other hand, it is noteworthy that the E238A mutation had a very specific effect on CFTR binding (namely this mutation did not inhibit binding to other proteins that interact with the SNARE motif such as SNAP23 and Munc18). In addition, the E238A mutant, but not the A240V/V244A mutant, was able to assemble into stable SNARE complexes like wild-type syntaxin 1A. Thus, although we cannot completely exclude the possibility that the E238A mutation affects CFTR binding as a consequence of altering the oligomerization or conformation of syntaxin 1A, it clearly has a very specific effect on the CFTR-syntaxin 1A interaction.

The CFTR-Syntaxin 1A Interaction Appears to Be Different from the Syntaxin 1A-Ca2+ Channel Interaction-- There is increasing evidence that syntaxin 1A modulates the activities of multiple ion channels at the plasma membrane. Such interactions may link the functions of certain ion channels to the exocytotic machinery. Catterall and colleagues (23) reported that syntaxin 1A biochemically interacts with the II/III cytosolic loop ("synprint loop") of the alpha 1B subunit of the N-type Ca2+ channel. However, functional studies using the oocyte expression system revealed that mutating hydrophobic residues Ala240 and Val244 of syntaxin 1A, located in the SNARE-stabilizing layers, resulted in appreciable loss of Ca2+ channel regulation but did not disrupt binding to the synprint motif. Furthermore, deletions within the II/III loop region of alpha 1B that eliminated the synprint site did not altogether abolish calcium channel modulation by syntaxin (14). This suggests that the binding and modulatory functions of syntaxin 1A can be disconnected in the case of the Ca2+ channel and/or that syntaxin 1A binds to multiple regions of this channel. In this respect, the regulation of CFTR by syntaxin 1A appears to be different. Point mutations in syntaxin 1A that disrupted CFTR binding also disrupted CFTR regulation. Also, the A240V/V244A double mutation did not affect the regulation of CFTR by syntaxin 1A but did destabilize core SNARE complexes, consistent with the predicted roles of these two hydrophobic residues. The latter results are in agreement with the findings of a related study in which mutations of the corresponding residues of Drosophila syntaxin 1 (A243V/V247A) severely compromised SNARE complex stability and disrupted synaptic transmission in flies (24). Thus, residues in the SNARE motif that facilitate the inhibition of N-type Ca2+ channels also govern SNARE complex formation and stability. In contrast, our results obtained with the S225A/E238A double mutant indicate that these hydrophilic residues are not involved in forming or stabilizing SNARE complexes, although mutating these residues had a pronounced effect on CFTR binding and regulation. This is the first report of mutations in the SNARE motif of syntaxin 1A that affect ion channel regulation without affecting SNARE complex assembly or stability.

The strong correlation between the binding of the various syntaxin 1A mutants to CFTR and their abilities to regulate CFTR channels in oocytes supports a simple model in which syntaxin 1A regulates CFTR via a specific protein-protein interaction. Whether this interaction affects the gating of the CFTR channel, its intracellular traffic, or both is a matter of some debate (25, 26), but the results of this and other studies (16) favor the view that syntaxin 1A must bind to CFTR in order to regulate its function. On this basis, one might conclude that syntaxin 1A by itself is sufficient to modulate CFTR activity in vivo. However, two observations indicate that there may be more than one SNARE protein involved in regulating CFTR at least in mammalian cells. First, we reported recently that CFTR channels preferentially associate with a t-SNARE heterodimer in mammalian cells that includes both SNAP-23 and syntaxin 1A. These two t-SNAREs appear to have additive or possibly cooperative effects on CFTR channel function (15). In support of these findings, the present results indicate that syntaxin 1A residues that mediate CFTR binding do not participate in SNARE-SNARE interactions, which, therefore, could allow syntaxin 1A to simultaneously complex with a t-SNARE partner via hydrophobic interactions as well as interact with CFTR via hydrophilic surface residues. Second, in the present study, we observed that the V248A syntaxin 1A peptide (unlike the wild-type syntaxin 1A peptide) was unable to rescue CFTR-mediated currents from inhibition by membrane-anchored syntaxin 1A in mouse L-fibroblasts. This contrasts with the inhibitory effect of full-length V248A syntaxin 1A on CFTR-mediated currents in oocytes. Conceivably, the V248A mutation inhibits the ability of the syntaxin 1A peptide to rescue CFTR channels from this t-SNARE complex in mammalian cells without directly affecting the binding of syntaxin 1A to the channel or the ability of the full-length protein to inhibit CFTR-mediated currents in oocytes. In support of this hypothesis, the V248A syntaxin 1A peptide could rescue CFTR-mediated currents from inhibition by full-length wild-type syntaxin 1A in the oocyte expression system, which, of course, lacks mammalian SNAP-23 (data not shown). However, more detailed studies will be required to determine whether the V248A mutation does indeed inhibit the ability of the syntaxin 1A peptide to disrupt the interactions between CFTR and the t-SNARE complex in mammalian cells.

The Syntaxin 1A-CFTR Interaction Can Be Uncoupled from the Syntaxin 1A-Munc-18 Interaction-- Munc-18a inhibits the syntaxin 1A-CFTR interaction due presumably to its ability to block the binding of syntaxin 1A to the CFTR channel (4). Unlike other proteins that interact with only the H3 region of syntaxin 1A, Munc-18 requires the entire NH2-terminal region of syntaxin 1A for high affinity binding (18). Moreover, Munc-18 is believed to bind to a closed syntaxin conformation, and mutations that destabilize this closed conformation compromise binding (9). In the present study, we identified a novel syntaxin 1A mutant (Y235A) that is inhibited for binding Munc-18 but is able to physically and functionally interact with CFTR. The Y235A mutation eliminates the ability of Munc-18 to neutralize the inhibitory effect of syntaxin 1A on CFTR activity presumably by disrupting the Munc-18-syntaxin 1A interaction. In the crystal structure of the syntaxin 1A-Munc-18a complex, Tyr235 of syntaxin 1A does not directly contact any residue in Munc-18a; rather, it is flanked on either side by residues that do directly interact with Munc-18a (27). Presumably, this mutation alters the local conformation of syntaxin 1A to a sufficient degree to inhibit Munc-18 binding.

In conclusion, our results indicate that syntaxin 1A biochemically and functionally interacts with the CFTR channel by a mechanism that is different from how this t-SNARE interacts with other SNAREs or apparently with voltage-gated calcium channels. The CFTR interaction involves surface-exposed hydrophilic residues that are unique to this isoform rather than hydrophobic residues that mediate SNARE complex assembly. The strong correlation between the binding and functional regulation of CFTR channels by the syntaxin 1A mutants that were tested favors the hypothesis that this t-SNARE regulates CFTR channels via a specific protein-protein interaction.

    ACKNOWLEDGEMENTS

We thank Shui He for making the syntaxin 1A mutants and Yongming Wang and Katie Davis for technical support. We also thank I. Bezprozvanny, R. Tsien, M. Bennett, and J. Pevsner for providing cDNA constructs and mutants.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant HL58341.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Physiology and Biophysics, Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, 1918 University Blvd., MCLM 985, Birmingham, AL 35294. Tel.: 205-934-3122; Fax: 205-934-5787; E-mail: kirk@physiology.uab.edu.

Published, JBC Papers in Press, November 22, 2002, DOI 10.1074/jbc.M211790200

2 A. P. Naren and K. L. Kirk, unpublished observations.

3 A. P. Naren and K. L. Kirk, unpublished results.

    ABBREVIATIONS

The abbreviations used are: CFTR, cystic fibrosis transmembrane conductance regulator; SNARE, soluble NSF attachment protein receptor; GST, glutathione S-transferase; BHK, baby hamster kidney; cpt-cAMP, 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., Mulligan, R. C., Smith, A. E., and Welsh, M. J. (1991) Science 253, 202-205[Medline] [Order article via Infotrieve]
2. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J. L., Drumm, M. L., Iannuzzi, M. C., Collins, F. S., and Tsui, L. C. (1989) Science 245, 1066-1073[Medline] [Order article via Infotrieve]
3. Naren, A. P., Nelson, D. J., Xie, W., Jovov, B., Pevsner, J., Bennett, M. K., Benos, D. J., Quick, M. W., and Kirk, K. L. (1997) Nature 390, 302-305[CrossRef][Medline] [Order article via Infotrieve]
4. Naren, A. P., Cormet-Boyaka, E., Fu, J., Villain, M., Blalock, J. E., Quick, M. W., and Kirk, K. L. (1999) Science 286, 544-548[Abstract/Free Full Text]
5. Naren, A. P., Di, A., Cormet-Boyaka, E., Boyaka, P. N., McGhee, J. R., Zhou, W., Akagawa, K., Fujiwara, T., Thome, U., Engelhardt, J. F., Nelson, D. J., and Kirk, K. L. (2000) J. Clin. Invest. 105, 377-386[Abstract/Free Full Text]
6. Sutton, R. B., Fasshauer, D., Jahn, R., and Brunger, A. T. (1998) Nature 395, 347-353[CrossRef][Medline] [Order article via Infotrieve]
7. Yang, B., Gonzalez, L., Jr., Prekeris, R., Steegmaier, M., Advani, R. J., and Scheller, R. H. (1999) J. Biol. Chem. 274, 5649-5653[Abstract/Free Full Text]
8. Weimbs, T., Low, S. H., Chapin, S. J., Mostov, K. E., Bucher, P., and Hofmann, K. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3046-3051[Abstract/Free Full Text]
9. Dulubova, I., Sugita, S., Hill, S., Hosaka, M., Fernandez, I., Sudhof, T. C., and Rizo, J. (1999) EMBO J. 18, 4372-4382[Abstract/Free Full Text]
10. Deken, S. L., Beckman, M. L., Boos, L., and Quick, M. W. (2000) Nat. Neurosci. 3, 998-1003[CrossRef][Medline] [Order article via Infotrieve]
11. Bezprozvanny, I., Scheller, R. H., and Tsien, R. W. (1995) Nature 378, 623-626[CrossRef][Medline] [Order article via Infotrieve]
12. Fili, O., Michaelevski, I., Bledi, Y., Chikvashvili, D., Singer-Lahat, D., Boshwitz, H., Linial, M., and Lotan, I. (2001) J. Neurosci. 21, 1964-1974[Abstract/Free Full Text]
13. Sheng, Z. H., Westenbroek, R. E., and Catterall, W. A. (1998) J. Bioenerg. Biomembr. 30, 335-345[CrossRef][Medline] [Order article via Infotrieve]
14. Bezprozvanny, I., Zhong, P., Scheller, R. H., and Tsien, R. W. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 13943-13948[Abstract/Free Full Text]
15. Cormet-Boyaka, E., Di, A., Chang, S. Y., Naren, A. P., Tousson, A., Nelson, D. J., and Kirk, K. L. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 12477-12482[Abstract/Free Full Text]
16. Naren, A. P., Quick, M. W., Collawn, J. F., Nelson, D. J., and Kirk, K. L. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 10972-10977[Abstract/Free Full Text]
17. Calakos, N., Bennett, M. K., Peterson, K. E., and Scheller, R. H. (1994) Science 263, 1146-1149[Medline] [Order article via Infotrieve]
18. Pevsner, J., Hsu, S. C., Braun, J. E., Calakos, N., Ting, A. E., Bennett, M. K., and Scheller, R. H. (1994) Neuron 13, 353-361[Medline] [Order article via Infotrieve]
19. Hao, J. C., Salem, N., Peng, X. R., Kelly, R. B., and Bennett, M. K. (1997) J. Neurosci. 17, 1596-1603[Abstract/Free Full Text]
20. Zhu, T., Dahan, D., Evagelidis, A., Zheng, S., Luo, J., and Hanrahan, J. W. (1999) J. Biol. Chem. 274, 29102-29107[Abstract/Free Full Text]
21. Hayashi, T., McMahon, H., Yamasaki, S., Binz, T., Hata, Y., Sudhof, T. C., and Niemann, H. (1994) EMBO J. 13, 5051-5061[Abstract]
22. Lerman, J. C., Robblee, J., Fairman, R., and Hughson, F. M. (2000) Biochemistry 39, 8470-8479[CrossRef][Medline] [Order article via Infotrieve]
23. Rettig, J., Sheng, Z. H., Kim, D. K., Hodson, C. D., Snutch, T. P., and Catterall, W. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 7363-7368[Abstract/Free Full Text]
24. Fergestad, T., Wu, M. N., Schulze, K. L., Lloyd, T. E., Bellen, H. J., and Broadie, K. (2001) J. Neurosci. 21, 9142-9150[Abstract/Free Full Text]
25. Chang, S. Y., Di, A., Naren, A. P., Palfrey, H. C., Kirk, K. L., and Nelson, D. J. (2002) J. Cell Sci. 115, 783-791[Abstract/Free Full Text]
26. Peters, K. W., Qi, J., Watkins, S. C., and Frizzell, R. A. (1999) Am. J. Physiol. 277, C174-C180[Medline] [Order article via Infotrieve]
27. Misura, K. M., Scheller, R. H., and Weis, W. I. (2000) Nature 404, 355-362[CrossRef][Medline] [Order article via Infotrieve]
28. Foster, L. J., Yeung, B., Mohtashami, M., Ross, K., Trimble, W. S., and Klip, A. (1998) Biochemistry 37, 11089-11096[CrossRef][Medline] [Order article via Infotrieve]
29. Corey, J. L., Davidson, N., Lester, H. A., Brecha, N., and Quick, M. W. (1994) J. Biol. Chem. 269, 14759-14767[Abstract/Free Full Text]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.